Evaluation of anti-Mullerian hormone as parameter of ovarian function in patients with systemic lupus erythematosus: A systematic review and meta-analysis
Downloads
HIGHLIGHTS
- Systemic Lupus Erythematosus (SLE) patients show a strong correlation between Anti-Mullerian Hormone (AMH) levels and ovarian function. Lower AMH levels indicate higher risk of impaired ovarian function and diminished reserve, as revealed by this meta-analysis.
- The comprehensive synthesis of available data in this study has important clinical implications for the management and counseling of Systemic Lupus Erythematosus (SLE) patients.
ABSTRACT
Objective: The assessment of ovarian function in patients with systemic lupus erythematosus (SLE) holds paramount importance for both clinicians and patients. This systematic review and meta-analysis delves into the role of anti-Mullerian hormone (AMH) as a key marker in evaluating ovarian function among SLE patients. Our study aims to provide valuable insights for clinicians managing ovarian function assessments and to offer practical recommendations for differences in therapy for patient care.
Materials and Methods: Studies comparing serum AMH levels between patients with systemic lupus erythematosus and healthy controls, as well as serum AMH levels between SLE patients, are necessary. PRISMA guidelines were used for this systematic review. Databases like PubMed, SCOPUS, EuropePMC, ProQuest, and Cochrane Central were searched using specific terms ("Anti-Mullerian Hormone" or "Ovarian Function" and "Systemic Lupus Erythematosus") for publications between 2000 and 2023. After removing duplicates, authors screened remaining articles based on abstracts, then reviewed selected abstracts in full-text. Studies meeting criteria were included based on unanimous agreement among investigators, with any disagreements resolved through author consensus.
Results: Data There were 12 eligible studies. In this research, we identified a link between SLE and diminished levels of AMH. Furthermore, it was observed that SLE patients undergoing cyclophosphamide (CYC) treatment also exhibited lowered AMH levels
Conclusion: The systematic review underscores the heightened risk of reduced ovarian reserve in SLE patients. Importantly, CYC treatment emerged as a factor contributing to compromised ovarian reserve. For individuals with systemic lupus erythematosus, particularly women in their reproductive years, assessing serum AMH levels can serve as a pivotal tool to inform therapeutic decisions and preserve ovarian health. Our study contributes to enhanced clinical understanding and patient care within the realm of SLE and reproductive health.
Bermas BL, Sammaritano LR. Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Fertil Res Pract [Internet]. 2015;1(1):1–7. Available from: http://dx.doi.org/10.1186/s40738-015-0004-3
Alarfaj AS, Khalil N. Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia. Clin Rheumatol. 2014;33(12):1731–6.
Chatziandreou E, Eustathiou A, Augoulea A, Armeni E, Mili N, Boutas I, et al. Antimüllerian Hormone as a Tool to Predict the Age at Menopause. Geriatrics. 2023;8(3):57.
Gao H, Ma J, Wang X, Lv T, Liu J, Ren Y, et al. Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age. Lupus. 2018;27(3):445–53.
Malheiro OB, Rezende CP, Rocha ALL, Del Puerto HL, Ferreira GA, Reis FM. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus. Gynecol Endocrinol. 2014;30(10):701–4.
De Araujo DB, Yamakami LYS, Aikawa NE, Bonfá E, Viana VST, Pasoto SG, et al. Ovarian reserve in adult patients with childhood-onset lupus: A possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503–11.
Gasparin AA, Souza L, Siebert M, Xavier RM, Chakr RMS, Palominos PE, et al. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus. Lupus. 2016;25(3):227–32.
Sterba Y, Tanner T, Wahezi D. Evaluation of ovarian reserve and function in adolescent females with systemic lupus erythematosus. Arthritis Rheumatol [Internet]. 2016;68:3233–4. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L613887240&from=export%0Ahttp://dx.doi.org/10.1002/art.39977
Mok CC, Chan PT, To CH. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus. Arthritis Rheum. 2013;65(1):206–10.
Morel N, Bachelot A, Chakhtoura Z, Ghillani-Dalbin P, Amoura Z, Galicier L, et al. Study of anti-müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin Endocrinol Metab. 2013;98(9):3785–92.
Ma W, Zhan Z, Liang X, Chen J, Huang X, Liao C. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy. J Women’s Heal. 2013;22(12):1023–7.
Isgro J, Nurudeen SK, Imundo LF, Sauer M V., Douglas NC. Cyclophosphamide exposure in pediatric systemic lupus erythematosus is associated with reduced serum anti-müllerian hormone levels. J Rheumatol. 2013;40(6):1029–31.
Kandil I. Fertility and Pregnancy Outcomes in Systemic Lupus Erythematosus Patients: A Study Using Antimullerian Hormone. Med Res Arch. 2022;10(11):1–11.
Di Mario C, Petricca L, Gigante MR, Barini A, Barini A, Varriano V, et al. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve. Endocrine [Internet]. 2019;63(2):369–75. Available from: http://dx.doi.org/10.1007/s12020-018-1783-1
Ulug P, Oner G, Kasap B, Akbas EM, Ozcicek F. Evaluation of Ovarian Reserve Tests in Women with Systemic Lupus Erythematosus. Am J Reprod Immunol. 2014;72(1):85–8.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):1–13.
Higgins DM, Lachappelle KM, Serowik KL, Driscoll MA, Lee A, Heapy AA. Predictors of participation in a nonpharmacological intervention for chronic back pain. Pain Med (United States). 2018;19:S76–83.
Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, et al. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertil Steril. 2019;111(2):357–62.
Du X, Ding T, Zhang H, Zhang C, Ma W, Zhong Y, et al. Age-Specific Normal Reference Range for Serum Anti-Müllerian Hormone in Healthy Chinese Han Women. Reprod Sci. 2016;23(8):1019–27.
Okunolap OT, Ajenifujap OK, Lotop MP, Salawup A, Omitindep OS, Akande J, et al. Age-specific nomograms for follicle stimulating hormone and anti-Mullerian hormone: A pilot study in Ile-Ife, Nigeria. Int J Reprod Biomed. 2016;14(12):777–82.
Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Müllerian hormone levels: Estimates from a large population-based sample. Climacteric. 2014;17(5):591–7.
Bozdag G, Calis P, Zengin D, Tanacan A, Karahan S. Age related normogram for antral follicle count in general population and comparison with previous studies. Eur J Obstet Gynecol Reprod Biol [Internet]. 2016;206:120–4. Available from: http://dx.doi.org/10.1016/j.ejogrb.2016.09.013
Loy SL, Cheung YB, Fortier MV, Ong CL, Tan HH, Nadarajah S, et al. Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore. PLoS One. 2017;12(12):1–9.
Nelson SM, Aijun S, Ling Q, Tengda X, Wei X, Yan D, et al. Ethnic discordance in serum anti-Müllerian hormone in healthy women: a population study from China and Europe. Reprod Biomed Online [Internet]. 2020;40(3):461–7. Available from: https://doi.org/10.1016/j.rbmo.2019.11.013
Velarde-Ochoa M del C, Esquivel-Valerio JA, Vega-Morales D, Skinner-Taylor CM, Galarza-Delgado DÁ, Garza-Elizondo MA. Anti-müllerian Hormone in Reproductive Age Women With Systemic Lupus Erythematosus. Reumatol Clínica (English Ed [Internet]. 2015;11(2):78–82. Available from: http://dx.doi.org/10.1016/j.reumae.2014.03.017
Hayat I, Ahmad A, Masud T, Ahmed A, Bashir S. Nutritional and Health Perspectives of Beans (Phaseolus vulgaris L.): An Overview. Crit Rev Food Sci Nutr [Internet]. 2014;54(5):580–92. Available from: http://dx.doi.org/10.1080/10408398.2011.596639
Gasparin AA, da Silva Chakr RM, Brenol CV, Palominos PE, Xavier RM, Souza L, et al. Anti-Müllerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review. Rev Bras Reumatol (English Ed. 2015;55(4):363–7.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
